Navigation Links
Renowned Experts to Share Early Insights Into Why Bariatric Surgery Improves Type 2 Diabetes for Many Patients
Date:6/24/2011

SAN DIEGO, June 24, 2011 /PRNewswire/ -- For several years, researchers have known that bariatric surgery can significantly reduce or even eliminate symptoms of type 2 diabetes and other metabolic diseases/disorders in many patients.(1,2,3,4) What has been unclear is why.

Through the Metabolic Applied Research Strategy (MARS), Ethicon Endo-Surgery Inc. (EES), a global leader in surgical innovations, and its academic research partners are beginning to understand why this happens, and why the most basic earlier assumptions about how bariatric surgery works are wrong.

Today, at a special media briefing in San Diego in advance of the 71st Scientific Sessions of the American Diabetes Association, EES and the following leading experts will share early insights from MARS and discuss potential implications for type 2 diabetes treatment:

  • Lee Kaplan, M.D., Ph.D., Director of the Weight Center and the Obesity Research Center at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School
  • Harold Lebovitz, M.D., Professor of Medicine in the Division of Endocrinology at The State University of New York Health Science Center at Brooklyn
  • Philip R. Schauer, M.D., Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, Director of Advanced Laparoscopic & Bariatric Surgery at the Cleveland Clinic

"In my practice, I routinely see patients who have remission of their type 2 diabetes within days or hours of gastric bypass, but we don't know why this occurs," said Dr. Schauer, who is speaking at the briefing. "Understanding how surgery has this effect has the potential to unlock new mechanisms of treating type 2 diabetes and, potentially, how to replicate the effect with less invasive procedures or even without surgery."

Clinical studies have demonstrated that some types of bariatric surgery can improve or resolve diabetes independent of weight loss, a benefit widely acknowledged by leading advocacy organizations such as the American Heart Association and the International Diabetes Federation.(1,2,3,4,5,6) Yet real-world practice is slow to catch up to science. In fact, about 15 million people in the U.S. have morbid obesity, but only 1 percent of the clinically eligible population is being treated for morbid obesity through bariatric surgery.(7)

MARS: A Groundbreaking Research Partnership

To address this need, EES has partnered with experts at the Metabolic Diseases Institute at the University of Cincinnati and the GI Metabolism Laboratory and Weight Center at the Massachusetts General Hospital on the Metabolic Applied Research Strategy (MARS) project.  MARS research is designed to help deconstruct, understand and reinvent bariatric procedures in ways that lead to new therapies that are less costly, less invasive, and more effective than current options.

"There is a critical public health need to find novel ways of addressing the obesity epidemic and related co-morbidities, including type 2 diabetes," said Jessica Grossman, M.D., Medical Director, Medical Affairs and MARS, Ethicon Endo-Surgery. "We believe this research will make a valuable contribution by guiding us in the development of innovative, less-invasive and more accessible treatment options."

MARS researchers have been working to deconstruct current bariatric surgical procedures and understand their mechanisms at tissue, cellular, molecular and genetic levels. This knowledge can be used to develop novel therapies that increase procedure effectiveness, decrease risks and costs, and identify patient populations who most benefit from them. It also can be used to reproduce the therapeutic mechanisms of current bariatric surgical procedures by using less-invasive, less-risky, or less-costly approaches.

Insights Into Bariatric Science and Real-World Application

In addition to MARS and other highlights of ongoing research into the physiological effects of bariatric surgery on diabetes, the briefing will address who bariatric surgery is best suited for and the real-world application of surgical interventions for people with type 2 diabetes.

EES will host the briefing on Friday, June 24, from 7-8 a.m. PST in the Gran Turismo room at the Keating Hotel in San Diego, Calif. In addition to Dr. Grossman, the session will also feature Mark Ortiz, a principal engineer with Ethicon Endo-Surgery and founding member of the Metabolic Applied Research Strategy (MARS).

About Ethicon Endo-Surgery

Ethicon Endo-Surgery develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. For more information, visit www.ethiconendosurgery.com.

(1) Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737

(2) Buchwald H. Consensus conference statement – Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers. Surgery for Obesity and Related Diseases 2005; 1:371-381.

(3) S Chikunguw et al. “Durable Resolution of Diabetes after Roux-en-Y Gastric Bypass Associated with Maintenance of Weight Loss.” SOARD. 200

(4) Dixon, JB et al. Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes. Journal of the American Medical Association. 2008; 299 (3): 316-323.

(5) Poirier P et al. “Bariatric Surgery and Cardiovascular Risk Factors: A Scientific Statement from the American Heart Association.” Circulation 2011 Apr 19;123(15):1683-701

(6) International Diabetes Federation Taskforce on Epidemiology and Prevention. “Bariatric Surgical and Procedural Interventions in the Treatment of Obese Patients with Type 2 Diabetes: A Position Statement” (March 2011).

(7) American Society for Metabolic & Bariatric Surgery. Metabolic  & Bariatric Surgery Fact Sheet (June 2010).


'/>"/>
SOURCE Ethicon Endo-Surgery
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
2. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
3. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
4. World Renowned Physician and Thought Leader Dr. Eric J. Topol to Highlight Digital Medicine Revolution at International CES 2010
5. Renowned Healthcare Advertising Agency LLNS Re-Launches With Ideas at the Center
6. World-Renowned Singer Youssou NDour Launches NightWatch Program
7. WaferGen Appoints World-Renowned Clinical Genomics Cancer Researcher Dr. Arul M. Chinnaiyan to Scientific Advisory Board
8. If Hospitals Want a Competitive Advantage - Use Brain Monitors in Surgeries Requiring Sedation says Renowned Anesthesiologist
9. Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors
10. Cellceutix CEO, Leo Ehrlich, Conducts Interview with "Biotech Stock Trader"; Dr. Paul Ginsberg, (Renowned Patent Attorney) Joins Cellceutix Advisory Board
11. Renowned New York Ophthalmologists, Drs. Glen Weiss and Robert Chen of Rockland Eye Physicians Use the AcrySof IQ ReSTOR IOL to Correct Cataracts Without Glasses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 2017  Vivify Health, the pioneer and market leader ... a very significant patent for the advancement of healthcare ... via digital health.  This landmark patent provides the company ... secures Vivify,s position as the leader in remote care.  ... first company to apply consumer mobile devices, wireless biometrics, ...
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy ... the preferred physical therapy provider for Derby City CrossFit, effective immediately. , In ... as quickly and effectively as possible, ProRehab’s sports physical therapists will work with ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... Greifensee, Switzerland (PRWEB) , ... April 25, 2017 ... ... product innovation targets, they rely on contracted partners to help with process innovation ... years of combined drug formulation experience along with state-of-the-art analytical equipment in support ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
Breaking Medicine News(10 mins):